Duality Biologics and BioNTech say interim data on one of their partnered ADCs look encouraging, with a preliminary cut from the trial showing that nearly …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The companies will partner to develop multitarget therapies that act on the GLP-1 receptor. Credit: Hunterframe / Shutterstock.com. Novo Nordisk has entered a research partnership
Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead to other
We’ve seen dramatic increases in life expectancy over the 19th and 20th centuries, thanks to healthier diets, medical advances and many other quality-of-life improvements.